AI accountability, faster FDA pathways, rare disease CMC review, and next-gen GLP-1 formulation lead this week’s PharmTech roundup.
|Articles|December 2, 2013
- Pharmaceutical Technology-12-02-2013
- Volume 37
- Issue 12
Tablet Tooling Coating Reduces Formulation Sticking
Author(s)Melanie Sena
Tablet Tooling Coating Reduces Formulation Sticking
PharmaCote CX and CX+, an enhanced Chromium Nitride, are a range of coatings developed to improve the performance of substrate material for punches and dies. The coating offers a smooth finish and anti-stick performance, the company reports. PharmaCote CX provides prolonged tooling life due to a multi-layered application. It also offers up to 13 times more corrosion resistance than PharmaCote HC (Hard Chromium) and up to two times the life of PharmaCote CN (Chromium Nitride).
Articles in this issue
almost 13 years ago
Rail-Mounted Fluid Bed Dryers Allow Cleaning Accessalmost 13 years ago
Biotechnology Innovation and Growth in Israelalmost 13 years ago
Drug Manufacturing Focus: Why India?almost 13 years ago
Clinical Trials Head East to Asiaalmost 13 years ago
Climate Change in Outsourcingalmost 13 years ago
Deficiencies Found in API Inspectionsalmost 13 years ago
Q&A with Brian Galliher, Cook Pharmicaalmost 13 years ago
Inspiring the Next Generationalmost 13 years ago
Establishing a Minimum Incubation Time for Biological IndicatorsRelated to this article
MASH and cardiomyopathy AI collaboration: AstraZeneca pays insitro $40M upfront for target discovery, then leads clinical development and CMC planning.
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about rare disease treatment development and navigating the FDA’s Rare Pediatric Disease Priority Review Voucher Program.
NVIDIA’s $250M, five-year compute donation funds UK agentic AI safety research, with implications for how GMP teams validate and govern autonomous AI.
Richard Jaenisch explains what FDA's real-world use case database means for CMC and quality teams navigating NAMs.
This article examines how modern automation platforms create the digital foundation required for Pharma 4.0 by integrating manufacturing systems, centralized data management, Industrial Internet of Things connectivity, electronic batch production records, and AI-driven analytics.
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
Trending on Pharmaceutical Technology
1
Germany’s Medical Biotechnology Sector is Flourishing
2
MASH and Cardiomyopathy Targets: Why AstraZeneca Chose insitro’s AI
3
Formulation Strategies for Next-Generation Multiagonists
4
First-in-Human Trial Speed: Why FDA Trails China
5